Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2008-01-16

Marvel LifeSciences Ltd withdraws its marketing authorisation applications for Insulin Human Rapid Marvel, Insulin Human Long Marvel and Insulin Human 30/70 Mix Marvel

View source ↗

Summary

Marvel LifeSciences Ltd has withdrawn its marketing authorization applications for three insulin products: Insulin Human Rapid Marvel, Insulin Human Long Marvel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Human 30/70 Mix Marvel (insulin)
  • Insulin Human Long Marvel (insulin)
  • Insulin Human Rapid Marvel (insulin)